# HISTOACRYL® Used for Embolization of Thoracoabdominal Artery Bleeding

> **NCT07753005** · — · NOT_YET_RECRUITING · sponsor: **Aesculap AG** · enrollment: 176 (estimated)

## Conditions studied

- Hemorrhage
- Gastrointestinal Hemorrhage
- Hemoptysis
- Postpartum Hemorrhage

## Interventions

- **DEVICE:** Embolization therapy

## Key facts

- **NCT ID:** NCT07753005
- **Lead sponsor:** Aesculap AG
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-09-30
- **Primary completion:** 2028-04
- **Final completion:** 2028-06
- **Target enrollment:** 176 (ESTIMATED)
- **Last updated:** 2026-08-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07753005

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07753005, "HISTOACRYL® Used for Embolization of Thoracoabdominal Artery Bleeding". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07753005. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*